Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
2(13%)
Results Posted
60%(6 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
5
33%
Ph not_applicable
5
33%
Ph phase_1
5
33%

Phase Distribution

5

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
5(33.3%)
Phase 2Efficacy & side effects
5(33.3%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(10)
Terminated(2)
Other(1)

Detailed Status

Completed10
Active, not recruiting2
Withdrawn1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
90.9%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (33.3%)
Phase 25 (33.3%)
N/A5 (33.3%)

Trials by Status

completed1067%
withdrawn17%
terminated17%
unknown17%
active_not_recruiting213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT00872625Phase 1

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Completed
NCT00951535Phase 2

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Active Not Recruiting
NCT01345851Not Applicable

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Active Not Recruiting
NCT02296684Phase 2

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Completed
NCT03176173Not Applicable

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Completed
NCT02186470Not Applicable

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

Completed
NCT04879849Phase 1

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Completed
NCT03623334Not Applicable

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

Completed
NCT01859689Phase 2

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Withdrawn
NCT00714753Phase 2

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

Completed
NCT01028885Phase 1

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Completed
NCT01024582Not Applicable

Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer

Completed
NCT00550654Phase 2

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Terminated
NCT01124682Phase 1

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Unknown
NCT00653757Phase 1

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

Completed

All 15 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
15